1,2-dipalmitoylphosphatidylcholine has been researched along with niacinamide in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (66.67) | 29.6817 |
2010's | 1 (33.33) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Pernak, A; Przyczyna, A; Rózycka-Roszak, B | 1 |
Kishore, N; Kundu, A | 1 |
Arora, J; Boonkaew, B; Callaghan, C; Chava, S; Dash, S; He, J; John, VT; Lee, BR; Liu, J; Maddox, MM; Mandava, SH | 1 |
3 other study(ies) available for 1,2-dipalmitoylphosphatidylcholine and niacinamide
Article | Year |
---|---|
A study on the interaction between 1-decyloxymethyl-3-carbamoylpyridinium salts and model membranes--the effect of counterions.
Topics: 1,2-Dipalmitoylphosphatidylcholine; Anions; Calorimetry, Differential Scanning; Liposomes; Magnetic Resonance Spectroscopy; Membranes, Artificial; Methyl Ethers; Molecular Structure; Niacinamide; Phosphatidylethanolamines; Pyridinium Compounds; Surface-Active Agents | 2004 |
Thermodynamics of alpha-lactalbumin-DL-alpha-dipalmitoylphosphatidylcholine interactions and effect of the antioxidant nicotinamide on these interactions.
Topics: 1,2-Dipalmitoylphosphatidylcholine; Antioxidants; Calorimetry, Differential Scanning; Lactalbumin; Models, Chemical; Niacinamide; Thermodynamics | 2005 |
Comparison of sorafenib-loaded poly (lactic/glycolic) acid and DPPC liposome nanoparticles in the in vitro treatment of renal cell carcinoma.
Topics: 1,2-Dipalmitoylphosphatidylcholine; Antineoplastic Agents; Carcinoma, Renal Cell; Cell Line, Tumor; Chemistry, Pharmaceutical; Chitosan; Dose-Response Relationship, Drug; Drug Carriers; Humans; Hydrophobic and Hydrophilic Interactions; Kidney Neoplasms; Kinetics; Lactic Acid; Liposomes; Nanoparticles; Nanotechnology; Niacinamide; Phenylurea Compounds; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Solubility; Sorafenib; Technology, Pharmaceutical | 2015 |